Evaluation of constrast enhanced MRI for therapeutic decisions in acute stroke with follow-up MRI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005197

Enrollment

100

Registered

2013-09-11

Start date

2013-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I63

Interventions

Group 1: Patients with acute stroke recieve a MRI exam within 72 hours after admission including contrast enhanced perfusion imaging and will be additionally evaluated after clinical criteria on disch

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a complete MRI emergency stroke protocoll including perfusion imaging within 9 hours of onset.

Exclusion criteria

Exclusion criteria: Contraindications to MRI according to routinely used consent forms including pacemaker, implanted drug pumps, pregnancy etc.

Design outcomes

Primary

Measure	Time frame
Prediction of reperfusion based on MRI baseline measurements (ADC, perfusion, FLAIR) in treated and untreated patients.	—

Secondary

Measure	Time frame
Prediction of 3-month clinical outcome based on baseline and short term MRI followup measurements in treated and untreated patients.	—

Countries

Germany

Contacts

Public ContactKarl Egger

Universitätsklinikum FreiburgNeuroradiologie

karl.egger@uniklinik-freiburg.de0049 761 270 50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026